John Cotton, MD
Orthopaedic Surgery · Panama City, FLNPI 1104987114
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (56.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 80.8% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2024 at $7,671 and has fallen 95.1% since, to $380 in 2025.
Across 118 payments — averaging $107.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$10K
- Vericel Corporation$2K
- Pacira Pharmaceuticals Incorporated$29
Across 4 payments — averaging $4062.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Smith+Nephew$16K
What the payments were for
- Consulting fees$6755%
- Speaking & faculty fees$7,21557%
- Travel & lodging$9557%
- Food & beverage$3,89131%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 96 | $10,290 |
| Vericel Corporation | 21 | $2,416 |
| Pacira Pharmaceuticals Incorporated | 1 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Bone Anchors with Arthroscopic Delivery System$6,098
- MACI$2,025
- Bioinductive Implant with Arthroscopic Delivery System - Medium$1,341
- REAL INTELLIGENCE$227
- T-Fix$170
- Journey II BCS$170
- PICO 7 Single Use Negative Pressure Wound Therapy$170
- REDAPT Revision Hip System$170
- NA$142
- REGENETEN Shoulder$120
- 500XL Light Source$105
How this compares
$12,735 in reported general payments places this provider in the 65th percentile of 1,263 orthopaedic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naloxone Hcl | 12 | $735 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 23 | $349 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $165 |
| Meloxicam | 14 | $15 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Panama City
- Andrew CooperClearwater$102M
- Richard HynesMelbourne$34.8M
- Mark FrankleTemple Terrace$31M
- Roy SandersTemple Terrace$19.6M
- George HaidukewychOrlando$10M
- Robert SantrockFernandina Beach$7.3M
- Martin RocheFt. Lauderdale$7.1M
- Steven LyonsTampa$6.7M
- Thomas BernasekTemple Terrace$6.4M
- Bryan SpringerJacksonville$6.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.